期刊
SINGAPORE MEDICAL JOURNAL
卷 56, 期 7, 页码 E124-E126出版社
SINGAPORE MEDICAL ASSOC
DOI: 10.11622/smedj.2015116
关键词
deferoxamine; ESRD; haemodialysis; HFE gene; secondary haemochromatosis
A 39-year-old woman with end-stage renal disease, which was maintained on haemodialysis, developed secondary haemochromatosis after receiving blood transfusions and intravenous iron supplementation without sufficient serum ferritin concentration monitoring. The patient received intravenous deferoxamine three times a week, combined with high-dose recombinant human erythropoietin therapy and haemodialysis. After three months, improvements in biochemical indicators and iron overload were noted.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据